| Date | Name | Title | Action | No Shares | Price Per Share |
|---|---|---|---|---|---|
Insider Transactions For DGX | |||||
| 2025-11-05 | Davis, J. E. | Director, CEO and President | Sold | 7143 | $175.57 |
| 2025-10-23 | Pfeiffer, Gary M | Director | Sold | 4413.28 | $190.58 |
| 2025-10-22 | Pfeiffer, Gary M | Director | Sold | 1482 | $182.40 |
| 2025-10-21 | Kuppusamy, Karthik | SVP, Clinical Solutions | Purchased | 15 | $189.08 |
| 2025-10-21 | Delaney, Mark E | SVP & Chief Commercial Officer | Purchased | 15 | $189.08 |
| 2025-10-21 | Gregg, Vicky B | Director | Purchased | 70 | $189.08 |
| 2025-10-21 | Carter, Robert B | Director | Purchased | 6 | $189.09 |
| 2025-10-21 | Samad, Sam | Executive Vice President & CFO | Purchased | 68 | $189.08 |
| 2025-10-21 | Plewman, Patrick | SVP for Diagnostic Services | Purchased | 46 | $189.08 |
| 2025-10-01 | Lassiter, Wright Iii | Director | Purchased | 157 | $0.00 |
| 2025-10-01 | Ring, Timothy M | Director | Purchased | 233 | $0.00 |
| 2025-09-26 | Prevoznik, Michael E | SVP & General Counsel | Sold | 144 | $188.66 |
| 2025-09-26 | Prevoznik, Michael E | SVP & General Counsel | Sold | 227 | $103.57 |
| 2025-09-26 | Prevoznik, Michael E | SVP & General Counsel | Sold | 83 | $187.22 |
| 2025-09-26 | Prevoznik, Michael E | SVP & General Counsel | Purchased | 227 | $103.57 |
| 2025-09-24 | Prevoznik, Michael E | SVP & General Counsel | Sold | 175 | $187.02 |
| 2025-09-24 | Prevoznik, Michael E | SVP & General Counsel | Purchased | 175 | $103.57 |
| 2025-09-24 | Prevoznik, Michael E | SVP & General Counsel | Sold | 175 | $103.57 |
| 2025-09-23 | Prevoznik, Michael E | SVP & General Counsel | Sold | 28288 | $103.57 |
| 2025-09-23 | Prevoznik, Michael E | SVP & General Counsel | Sold | 28288 | $187.12 |